World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
77
Citations
42521
World Ranking
1784
National Ranking
15

Overview

Chuan Qin is affiliated with Peking Union Medical College Hospital in China, focusing primarily on research in the field of Medicine. The scientist's work spans several subfields including Infectious Diseases, Molecular Biology, Epidemiology, Neurology, and Immunology.

Their research topics cover a range of areas with particular attention to SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, and investigations into the long-term effects of COVID-19. Additionally, they have contributed to studies on viral gastroenteritis research and epidemiology, animal virus infections, Alzheimer's disease research and treatments, as well as gut microbiota and health.

Chuan Qin's recent publications demonstrate involvement in critical COVID-19 research. Notable papers include:

  • Development of an inactivated vaccine candidate for SARS-CoV-2, 2020, Science
  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, 2020, Cell Research
  • Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells, 2020, Cell
  • The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice, 2020, Nature
  • Animal models for COVID-19, 2020, Nature

Frequent collaborators in their research include Linlin Bao, Jiangning Liu, Wei Deng, Qi Lv, and Pin Yü. This network has contributed to a substantial body of research in their shared fields.

Chuan Qin has published extensively in several scientific venues. The most common publication sources are Animal Models and Experimental Medicine, bioRxiv (Cold Spring Harbor Laboratory), Signal Transduction and Targeted Therapy, Zenodo (CERN European Organization for Nuclear Research), and Nature.

Best Publications

  • Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.

    Chuan Qin;Luoqi Zhou;Ziwei Hu;Shuoqi Zhang

  • A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

    Keiji Kuba;Yumiko Imai;Shuan Rao;Hong Gao

  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

    Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu

  • Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.

    Li Li Ren;Ye Ming Wang;Zhi Qiang Wu;Zi Chun Xiang

  • Development of an inactivated vaccine candidate for SARS-CoV-2.

    Qiang Gao;Linlin Bao;Haiyan Mao;Lin Wang

  • The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.

    Linlin Bao;Wei Deng;Baoying Huang;Hong Gao

  • From SARS to MERS, Thrusting Coronaviruses into the Spotlight

    Zhiqi Song;Yanfeng Xu;Linlin Bao;Ling Zhang

  • Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.

    Yunlong Cao;Bin Su;Xianghua Guo;Wenjie Sun

  • Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

    Li Liu;Qiang Wei;Qingqing Lin;Jun Fang

  • Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.

    Hui Wang;Yuntao Zhang;Baoying Huang;Wei Deng

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.

    Jingyun Yang;Wei Wang;Zimin Chen;Shuaiyao Lu

  • Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

    Jasper Fuk Woo Chan;Yanfeng Yao;Man Lung Yeung;Wei Deng

  • Immunogenicity of a DNA vaccine candidate for COVID-19.

    Trevor R.F. Smith;Ami Patel;Stephanie Ramos;Dustin Elwood

  • A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.

    Lianpan Dai;Lianpan Dai;Tianyi Zheng;Kun Xu;Yuxuan Han

  • Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.

    Wei Deng;Linlin Bao;Jiangning Liu;Chong Xiao

  • Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques

    Li Liu;Qiang Wei;Xavier Alvarez;Haibo Wang

  • Dual Functions of Microglia in Ischemic Stroke

    Chuan Qin;Luo Qi Zhou;Xiao Tong Ma;Zi Wei Hu

  • Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease

    Ling Zhang;Ying Wang;Xia Xiayu;Changhua Shi

  • Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways

    Hin Chu;Jie Zhou;Bosco Ho-Yin Wong;Cun Li

  • Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China.

    Xiaoquan Lai;Minghuan Wang;Chuan Qin;Li Tan

  • Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China

    Chuan Qin;Luoqi Zhou;Ziwei Hu;Shuoqi Zhang

Frequent Co-Authors

Erwan Bezard
Erwan Bezard University of Bordeaux
George F. Gao
George F. Gao Chinese Center For Disease Control and Prevention
Qin Li
Qin Li Peking Union Medical College Hospital
Zhiwei Chen
Zhiwei Chen University of Hong Kong
Qi Jin
Qi Jin Peking Union Medical College Hospital
feng gao
feng gao Duke University
Shibo Jiang
Shibo Jiang Fudan University
Kwok-Yung Yuen
Kwok-Yung Yuen University of Hong Kong
Yuhai Bi
Yuhai Bi Chinese Academy of Sciences
Qiang Gao
Qiang Gao Beihang University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining Immunology with healthcare, exploring online nursing programs can be a great option. Many universities offer online nursing programs for non nurses, designed to help individuals without prior nursing experience transition into the field smoothly.

Accelerated options such as accelerated BSN programs for non nurses allow students to earn a Bachelor of Science in Nursing quickly, making them ideal for immunology graduates aiming to enter clinical roles.

For those seeking to start with foundational clinical experience, easy LPN programs to get into provide an accessible pathway into licensed practical nursing, offering vital patient care skills aligned with immunology knowledge.

Finally, pursuing advanced practice roles is possible through the easiest nurse practitioner program, which equips students to function at a higher clinical level and specialize in immunology-related care.

Best Scientists Citing Chuan Qin

Trending Scientists